Clinical Trials Browser

Completed × Carcinoma, Hepatocellular × Bortezomib × Clear all

NCT00083226 2014-10-30

Doxorubicin and Bortezomib in Treating Patients With Liver Cancer

Phase 2 Completed

42 enrolled 8 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT00077441 2013-06-04

Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular